PT1131331E - AQUALIDITIES OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS - Google Patents

AQUALIDITIES OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS

Info

Publication number
PT1131331E
PT1131331E PT99954277T PT99954277T PT1131331E PT 1131331 E PT1131331 E PT 1131331E PT 99954277 T PT99954277 T PT 99954277T PT 99954277 T PT99954277 T PT 99954277T PT 1131331 E PT1131331 E PT 1131331E
Authority
PT
Portugal
Prior art keywords
aqualidities
members
antibiotic agents
antibiotic
agents
Prior art date
Application number
PT99954277T
Other languages
Portuguese (pt)
Inventor
Robert John Rafka
Barry James Morton
Colman Brendan Ragan
Peter Bertinato
John Philip Dirlam
Alan Elwood Blize
Carl Bernard Ziegler
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22327457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1131331(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT1131331E publication Critical patent/PT1131331E/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
PT99954277T 1998-11-20 1999-11-09 AQUALIDITIES OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS PT1131331E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10939998P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
PT1131331E true PT1131331E (en) 2004-06-30

Family

ID=22327457

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99954277T PT1131331E (en) 1998-11-20 1999-11-09 AQUALIDITIES OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS

Country Status (46)

Country Link
US (1) US6329345B1 (en)
EP (1) EP1131331B1 (en)
JP (1) JP3842973B2 (en)
KR (1) KR100477774B1 (en)
CN (2) CN101367853A (en)
AP (1) AP2001002142A0 (en)
AR (3) AR019496A1 (en)
AT (1) ATE260927T1 (en)
AU (1) AU766106B2 (en)
BG (1) BG65107B1 (en)
BR (2) BRPI9915480B1 (en)
CA (1) CA2351429C (en)
CO (1) CO5380019A1 (en)
CZ (1) CZ303099B6 (en)
DE (1) DE69915336T2 (en)
DK (1) DK1131331T3 (en)
DZ (1) DZ2944A1 (en)
EA (2) EA005156B1 (en)
EG (1) EG23823A (en)
ES (1) ES2216581T3 (en)
GT (1) GT199900198A (en)
HK (1) HK1041269A1 (en)
HR (1) HRP20010374B1 (en)
HU (1) HU229008B1 (en)
ID (1) ID28548A (en)
IL (3) IL142631A0 (en)
IS (1) IS2350B (en)
MA (1) MA26707A1 (en)
ME (1) ME00467B (en)
MY (1) MY122353A (en)
NO (3) NO319796B1 (en)
NZ (1) NZ511199A (en)
OA (1) OA11713A (en)
PA (1) PA8485601A1 (en)
PE (1) PE20001378A1 (en)
PL (1) PL198580B1 (en)
PT (1) PT1131331E (en)
RS (1) RS50302B (en)
SI (1) SI1131331T1 (en)
SK (1) SK284607B6 (en)
TN (1) TNSN99214A1 (en)
TW (2) TWI243824B (en)
UA (1) UA70972C2 (en)
UY (1) UY25805A1 (en)
WO (1) WO2000031097A1 (en)
ZA (1) ZA200104019B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (en) 1997-06-11 1999-03-08 Pfizer Prod Inc DERIVATIVES OF 9 - DESOFO - 9 AZA - 9A - HOMOERITROMICINA A - C - 4 SUBSTITUTED.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
UA70972C2 (en) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-membered azalides and use thereof as antibiotics
IL145739A0 (en) * 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
OA12257A (en) * 2000-04-27 2003-11-06 Pfizer Prod Inc the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.
IL158059A0 (en) * 2001-04-27 2004-03-28 Pfizer Prod Inc Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
JP4311203B2 (en) * 2001-08-08 2009-08-12 大正製薬株式会社 11a-azalide compound and method for producing the same
ES2552682T3 (en) * 2003-03-10 2015-12-01 Merck Sharp & Dohme Corp. Novel antibacterial agents
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
CN1882360A (en) * 2003-11-21 2006-12-20 辉瑞产品公司 The use of antibiotics as vaccine adjuvants
US8097708B2 (en) * 2006-02-07 2012-01-17 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
US8940880B2 (en) 2010-09-20 2015-01-27 Novartis Ag Process for the preparation of 9-deoxo-9a-homoerythromycin A, modified in the C-4″ of the cladinose ring by an epoxide group
CN102295672B (en) * 2011-07-13 2014-06-04 武汉回盛生物科技有限公司 Synthetic method for tylosin
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN102786569B (en) * 2012-09-07 2016-12-07 安徽中升药业有限公司 The preparation method of Tulathromycin intermediate and preparation method thereof and Tulathromycin
WO2015014907A1 (en) * 2013-07-31 2015-02-05 Farma Grs, D.O.O. Process for preparation of tulathromycin
CN105085590A (en) * 2014-05-16 2015-11-25 普莱柯生物工程股份有限公司 Macrolide compound
CN104725446B (en) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 A kind of method that Tulathromycin A and Tulathromycin B is separated in the crude product from Tulathromycin
US20220177508A1 (en) * 2018-11-19 2022-06-09 Zikani Therapeutics, Inc. C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof
SG11202105227QA (en) * 2018-11-19 2021-06-29 Zikani Therapeutics Inc C10-alkylene substituted 13-membered macrolides and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
YU44599B (en) * 1986-09-12 1990-10-31 Pliva Pharm & Chem Works Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
US5106961A (en) 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
GB2327084A (en) * 1997-07-08 1999-01-13 Merck & Co Inc 9a-Aza-3-ketolide antibiotics
UA70972C2 (en) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-membered azalides and use thereof as antibiotics

Also Published As

Publication number Publication date
DK1131331T3 (en) 2004-06-14
MY122353A (en) 2006-04-29
HUP0104313A3 (en) 2003-12-29
EA009729B1 (en) 2008-02-28
HRP20010374B1 (en) 2006-09-30
AU1068600A (en) 2000-06-13
EA200400701A1 (en) 2004-12-30
IS2350B (en) 2008-04-15
SI1131331T1 (en) 2004-08-31
ID28548A (en) 2001-05-31
GT199900198A (en) 2001-05-11
JP2002530422A (en) 2002-09-17
IL142631A0 (en) 2002-03-10
PL347784A1 (en) 2002-04-22
EP1131331A1 (en) 2001-09-12
CZ20011754A3 (en) 2002-03-13
HRP20010374A2 (en) 2002-06-30
DZ2944A1 (en) 2004-03-15
NO20012464D0 (en) 2001-05-18
CZ303099B6 (en) 2012-04-04
DE69915336T2 (en) 2005-01-13
EA005156B1 (en) 2004-12-30
IS5918A (en) 2001-04-17
CO5380019A1 (en) 2004-03-31
WO2000031097A1 (en) 2000-06-02
IL189430A (en) 2010-05-31
HK1041269A1 (en) 2002-07-05
HU229008B1 (en) 2013-07-29
EA200100416A1 (en) 2001-10-22
ME00467B (en) 2011-10-10
BG65107B1 (en) 2007-02-28
HUP0104313A2 (en) 2002-02-28
UY25805A1 (en) 2001-08-27
CN1326460A (en) 2001-12-12
NO20050904L (en) 2001-07-17
YU33401A (en) 2004-05-12
KR100477774B1 (en) 2005-03-21
NO20012464L (en) 2001-07-17
IL142631A (en) 2010-05-31
NO319796B1 (en) 2005-09-19
SK6632001A3 (en) 2002-07-02
AU766106B2 (en) 2003-10-09
NO330249B1 (en) 2011-03-14
NO20050893L (en) 2001-07-17
BR9915480A (en) 2001-07-31
EP1131331B1 (en) 2004-03-03
MA26707A1 (en) 2004-12-20
BRPI9915480B8 (en) 2022-05-10
OA11713A (en) 2005-01-25
TWI243824B (en) 2005-11-21
AR019496A1 (en) 2002-02-20
EG23823A (en) 2007-09-19
CN101367853A (en) 2009-02-18
BG105600A (en) 2001-12-29
IL189430A0 (en) 2008-06-05
DE69915336D1 (en) 2004-04-08
TW200404077A (en) 2004-03-16
UA70972C2 (en) 2004-11-15
KR20010086043A (en) 2001-09-07
AR059523A2 (en) 2008-04-09
PE20001378A1 (en) 2000-12-14
CA2351429A1 (en) 2000-06-02
ES2216581T3 (en) 2004-10-16
CA2351429C (en) 2005-07-12
TNSN99214A1 (en) 2005-11-10
SK284607B6 (en) 2005-07-01
ZA200104019B (en) 2002-06-17
ATE260927T1 (en) 2004-03-15
NO329629B1 (en) 2010-11-22
RS50302B (en) 2009-09-08
JP3842973B2 (en) 2006-11-08
BRPI9915480B1 (en) 2015-12-29
AR059524A2 (en) 2008-04-09
PA8485601A1 (en) 2000-09-29
TWI243825B (en) 2005-11-21
NZ511199A (en) 2003-08-29
AP2001002142A0 (en) 2001-05-09
US6329345B1 (en) 2001-12-11
PL198580B1 (en) 2008-06-30

Similar Documents

Publication Publication Date Title
PT1131331E (en) AQUALIDITIES OF 13 MEMBERS AND THEIR USE AS ANTIBIOTIC AGENTS
NO20000125D0 (en) Tiadiazolyl and oxadiazolylphenyloxazolidinone antibacterial agents
PT941056E (en) ESFINGOMYELINASE COMPOSITIONS AND THEIR USE
PT994865E (en) TRIAZOL COMPOUNDS AND THEIR USE AS DOPAMINE-D3 LIGANTS
DE69621528D1 (en) ANTI-INFLAMATIVE AGENTS
DE69635673D1 (en) BLUTSAMMELSYSTEM AND COUPLING
LV11684A (en) Pesticide
DE69534990D1 (en) CONTRAST AGENTS
BR9612426A (en) Carbomoyloxy derivatives and their application as antibacterials
DE69520639D1 (en) Disinfectant composition
BR9606984A (en) Broom and broom set
DE69418463D1 (en) SELF-CLEANING ANIMAL TOILET
DE69506120D1 (en) DISINFECTANT
ATE225190T1 (en) DISINFECTANT
PT1070077E (en) LACTAMA CETOLIDOS WITH 15 MEMBERS WHO HAVE ANTIBACTERIAL ACTIVITY
DE69520235D1 (en) ANTI-SWEATANT AGENTS
PT764157E (en) BENZOPYRANES AND THEIR USE AS THERAPEUTIC AGENTS
DE69619763D1 (en) Positive working photolock composition and photosensitizers
DE69636506D1 (en) Antibacterial and fungicidal chain
PT858445E (en) NEW ¬ (3-ALCOXY-PHENOXY) -ETIL | -DIALQUILAMINE DERIVATIVES AND THEIR USE AS LOCAL ANTHRODESIS
PT1140952E (en) ORGANOPHOSPHORIC COMPOUNDS AND THEIR USE
NO982927D0 (en) Biologically active benzothiazolone ethanamines
PT961774E (en) PYRAZOL-4-YO-BENZOYL DERIVATIVES AND THEIR USE AS HERBICIDES
PT763535E (en) PIPERIDYLMETYLOLOZAZOLIDIN-2-ONE DERIVATIVES THEIR PREPARATION AND ITS USE AS COMPOUNDS WITH CNS ACTIVITY
BR9503633A (en) Disinfectant composition